A $20 + Billion target, Vivtar and 173+ more...

how about you give investors more information to better gauge this thing?

How undervalued are we?

Oh, and don't forget the record revenue number projection for fiscal '08.

Will Vivitar settle or go the distance? Considering what the parent company is facing, do they want another unknown dark cloud hanging overhead?